Bayer Cornering Market On Pet Tick Meds, Antitrust Suit Says
Bayer HealthCare is hatching illegal deals with retailers and distributors to keep generic tick and flea medications from encroaching on its territory and owes a generic pet medication maker $114 million...To view the full article, register now.
Already a subscriber? Click here to view full article